Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOX-H94 in Cancer Patients With Anemia of Chronic Disease
NCT01691040Phase 2Completed
- Sponsor
- TME Pharma
- Start
- Sep 2012
- Primary completion
- Nov 2013
- Countries
- 3
01
Overview
A Phase 2 trial of lexaptepid pegol in anemia of chronic disease (ACD), sponsored by TME Pharma. Started Sep 2012; status: completed.
02
Drugs
lexaptepid pegol
03
Conditions
anemia of chronic disease (ACD)
Beyond the preview
Go deeper on NCT01691040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01691040.